Sarah Pringle

Ex-KKR exec Jim Momtazee unveils a new healthcare-focused investment firm and Precision Medical Group is up for sale.

StoneBridge, with capital commitments from sources including MPT and Oaktree Capital Management, may put in an offer for a distressed hospital as soon as this week.

Berkshire, which co-led a $275 million investment in Precision in late 2017 alongside TPG Growth, intends to remain invested in the provider of clinical trial and drug commercialization services.

The registry has partnered with a dozen-plus diagnostic companies on a mission to educate the government where the nation's testing shortages lie.

Waystar, eSolutions and their respective PE backers first met last fall, well before a virtual sale process for the revenue-cycle-management firm kicked off in July.

EQT-backed Waystar is buying Francisco Partners' eSolutions in a deal valued between $1.3 billion and $1.4 billion.

EQT and CPPIB last summer agreed to acquire a majority stake in Waystar in a $2.7 billion deal, leaving previous investor Bain Capital with a minority stake.

The PE firm sees robust growth potential for AMT, fueled by the country's diabetes problem, favorable reimbursement dynamics and increasing demand across post-acute care settings.

SPACs are more than the flavor of the month--they're here to stay.

The SPAC route allows Cerevel to combine two transactions into a single event, all the while presenting a more educated investor base pre-IPO, a senior executive on Bain's life sciences team said.